Ainos, Inc. (AIMD) vs NeuroOne Medical Technologies Corporation (NMTC)
A side-by-side comparison of Ainos, Inc. and NeuroOne Medical Technologies Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AIMD
Ainos, Inc.
$1.31HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
NMTC
NeuroOne Medical Technologies Corporation
$1.11HealthcareDelayed quote: Oct 6, 2026, 3:02 PM EDT
Total return — AIMD vs NMTC
growth of $100 · dividends reinvested · last 6yAIMD -97.7% (-46.6%/yr)NMTC -96.2% (-42.1%/yr)NMTC compounded faster over this window
AIMD NMTC
AIMD vs NMTC: by the numbers
- •NMTC is the larger company ($10M vs $10M market cap).
- •Both run net losses; NMTC's is the smaller (-71.51% vs -106283.32% net margin).
- •AIMD grew revenue faster over the past five years (49.62% vs 37.21% CAGR).
Metrics side by side
Valuation
| Metric | AIMD | NMTC |
|---|---|---|
| P/S ratio | 709.38 | 0.97 |
| P/B ratio | 2.94 | 2.56 |
Profitability
| Metric | AIMD | NMTC |
|---|---|---|
| Gross margin | -3767.20% | 67.30% |
| Operating margin | -11268.32% | -34.94% |
| Net margin | -106283.32% | -71.51% |
| ROE | -440.15% | -189.76% |
| ROIC | -80.51% | -183.45% |
Growth (annualized)
| Metric | AIMD | NMTC |
|---|---|---|
| Revenue CAGR (5Y) | 49.62% | 37.21% |
| Total return CAGR (5Y) | -58.50% | -46.02% |
Frequently asked
- Which has grown faster, AIMD or NMTC?
- Over the past five years, AIMD grew revenue faster — AIMD at a 49.62% CAGR versus NMTC at 37.21%.
- How have AIMD and NMTC total returns compared?
- Over the past 5 years, AIMD delivered -58.50% and NMTC delivered -46.02% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Ainos ROENeuroOne Medical Technologies ROEAinos operating marginNeuroOne Medical Technologies operating marginAinos revenue growthNeuroOne Medical Technologies revenue growthAinos free cash flowNeuroOne Medical Technologies free cash flow
Ainos & NeuroOne Medical Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.